Human African Trypanosomiasis Progress and Stagnation

被引：37

作者：

Bottieau, Emmanuel ^{[1
]}

Clerinx, Jan ^{[1
]}

机构：

[1] Inst Trop Med, Dept Clin Sci, Natl Str 155, B-2000 Antwerp, Belgium

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2019年 / 33卷 / 01期

关键词：

Human African trypanosomiasis; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Clinical presentation; Diagnosis; Treatment; BRUCEI-GAMBIENSE TRYPANOSOMIASIS; EFLORNITHINE COMBINATION THERAPY; RAPID DIAGNOSTIC-TEST; SLEEPING SICKNESS; ORAL FEXINIDAZOLE; CLINICAL-ASPECTS; MELARSOPROL; MULTICENTER; INFECTIONS;

D O I：

10.1016/j.idc.2018.10.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Control efforts have considerably reduced the prevalence of human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in West/Central Africa and to Trypanosoma brucei rhodesiense in East Africa. Management of T brucei gambiense HAT has recently improved, with new antibody-based rapid diagnostic tests suited for mass screening and clinical care, and simpler treatments, including the nifurtimox-eflornithine combination therapy and the new oral drug fexinidazole to treat the second stage of the disease. In contrast, no major advance has been achieved for the treatment of T brucei rhodesiense HAT, a zoonosis that occasionally affects short-term travelers to endemic areas.

引用

页码：61 / +

页数：18

共 79 条

[1]

Aksoy S., 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1111/J.1755-6724.1942.MP223-4016.X

[2] Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo [J].

Alirol, Emilie ;

Schrumpf, David ;

Heradi, Josue Amici ;

Riedel, Andrea ;

de Patoul, Catherine ;

Quere, Michel ;

Chappuis, Francois .

CLINICAL INFECTIOUS DISEASES, 2013, 56 (02) :195-203

[3] A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis [J].

Babokhov, Peter ;

Sanyaolu, Adekunle O. ;

Oyibo, Wellington A. ;

Fagbenro-Beyioku, Adetayo F. ;

Iriemenam, Nnaemeka C. .

PATHOGENS AND GLOBAL HEALTH, 2013, 107 (05) :242-252

[4]

Bisser S, 2016, PLOS NEGLECT TROP D, V10, P1

[5] Clinical aspects of 2541 patients with second stage human African trypanosomiasis [J].

Blum, J ;

Schmid, C ;

Burri, C .

ACTA TROPICA, 2006, 97 (01) :55-64

[6] Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis [J].

Blum, J ;

Nkunku, S ;

Burri, C .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (05) :390-400

[7] Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis) [J].

Blum, Johannes A. ;

Burri, Christian ;

Hatz, Christoph ;

Kazumba, Leon ;

Mangoni, Patrick ;

Zellweger, Michael J. .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 (12) :1422-1432

[8] Sleeping glands? -: The role of endocrine disorders in sleeping sickness (Tb. gambiense human African trypanosomiasis) [J].

Blum, Johannes A. ;

Schmid, Caecilia ;

Hatz, Christoph ;

Kazumba, Leon ;

Mangoni, Patrick ;

Rutishauser, Jonas ;

la Torre, Anna ;

Burri, Christian .

ACTA TROPICA, 2007, 104 (01) :16-24

[9]

BOA YF, 1988, B SOC PATHOL EXOT, V81, P427

[10] A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo [J].

Boelaert, Marleen ;

Mukendi, Deby ;

Bottieau, Emmanuel ;

Lilo, Jean Roger Kalo ;

Verdonck, Kristien ;

Minikulu, Luigi ;

Barbe, Barbara ;

Gillet, Philippe ;

Yansouni, Cedric P. ;

Chappuis, Francois ;

Lutumba, Pascal .

EBIOMEDICINE, 2018, 27 :11-17

← 1 2 3 4 5 6 7 8 →